Traders should monitor initial trading volume and price volatility when AIDX begins trading on Nasdaq, as direct listings often exhibit greater price swings due to lack of price stabilization typically provided by underwriters. The absence of new capital means the company's balance sheet remains unchanged.
Price Chart
Executive Summary
20/20 Biolabs, Inc. (AIDX) has officially gone public via a direct listing, with its S-1 registration becoming effective on April 10, 2026. The company is now eligible to begin trading on Nasdaq under the symbol AIDX, marking its transition to a publicly traded entity without raising new capital through an underwritten IPO.
Key Facts
- The EFFECT filing confirms the effectiveness of Form S-1 (File No. 333-294903) as of April 10, 2026.
- This is a direct listing, not a traditional IPO — no new shares are being issued and the company will not receive proceeds from the resale of existing shares.
- Selling stockholders may offer up to 15.16 million shares registered for resale, originally detailed in the S-1/A filed January 21, 2026.
- The company is an emerging growth company and will benefit from reduced reporting requirements under the JOBS Act.
Financial Impact
No immediate financial impact to the company as it receives no proceeds from the resale of shares by selling stockholders.
Risk Factors
- High volatility at open due to untested price discovery mechanism in a direct listing.
- No lock-up period may allow early selling pressure from existing shareholders.
- Limited public float could lead to low liquidity initially.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001159 |
| Document: 9999999995-26-001159-index.html | 9999999995-26-001159 |
| Document: 9999999995-26-001159.txt | 9999999995-26-001159 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | DEFA14A | $0.2507 | awaiting T+5 | — | $0.2325 (−7.26%) |
Oct 21, 2026 5d ago | DEF 14A | $0.2507 | awaiting T+5 | — | $0.2325 (−7.26%) |
Aug 17, 2026 10w ago | 8-K | $0.5200 $0.5282 | ▲ +1.58% | ▲ +1.78% | $0.2325 (−55.29%) |
Aug 17, 2026 10w ago | Press Release | $0.5503 $0.5182 | ▼ −5.83% | ▼ −4.64% | $0.2325 (−57.75%) |
Aug 5, 2026 11w ago | 8-K | $0.4413 $0.4610 | ▲ +4.46% | ▲ +4.11% | $0.2325 (−47.31%) |
Jul 1, 2026 16w ago | 8-K | $0.6095 $0.5851 | ▼ −4.00% | ▼ −4.26% | $0.2325 (−61.85%) |
Jun 23, 2026 17w ago | DEFA14A | $0.5669 $0.6095 | ▼ −7.51% | ▼ −5.81% | $0.2325 (+58.99%) |
May 26, 2026 21w ago | 8-K | $0.9700 $0.8400 | ▼ −13.40% | ▼ −13.87% | $0.2325 (−76.03%) |
May 20, 2026 22w ago | 8-K | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2325 (+80.79%) |
May 20, 2026 22w ago | Press Release | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2325 (+80.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers